Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Arthritis, Psoriatic

• A Study to Evaluate the Safety and Tolerability, and the Efficacy of Si-544 in Adults With Psoriasis Vulgaris or Psoriatic Arthritis
• Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis
• A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
• Bioequivalence Study of Two Products of Apremilast 30 mg Tablets in Healthy, Adult, Human Subjects
• A Study of Ixekizumab (LY2439821) in Participants Aged ≥18 Years With Moderate-to-Severe Plaque or Active Psoriatic Arthritis in India
• A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
• VTX958 Versus Placebo for the Treatment of Active Psoriatic Arthritis (Tranquility-PsA)
• FAPI-PET/CT in Psoriatic Arthritis
• Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
• Evaluation of Sonelokimab for the Treatment of Patients With Active Psoriatic Arthritis
• Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients (EVOLUTION)
• Psoriatic Arthritis Study of Izokibep
• Study of ATI-450 vs Placebo in Patients With Moderate to Severe Psoriatic Arthritis
• Effect of Bimekizumab in Patients With Psoriasis Vulgaris and Active Psoriatic Arthritis
• A Study on Pharmacokinetics and Safety of BAT2506 Injection Versus Simponi®
• A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Subjects With Active Psoriatic Arthritis
• Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging
• A Long-term Extension Study of Ustekinumab in Pediatric Participants
• A Study of Ustekinumab in Pediatric Participants With Active Juvenile Psoriatic Arthritis
• A Study of Guselkumab and Risankizumab in Healthy Participants and Participants With Psoriatic Arthritis
• COVID-19 VaccinE Response in Rheumatology Patients
• A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis
• Study of the Effectiveness and Safety of SHR-1314 for Psoriatic Arthritis
• Comparative Study of BAT2506 With Simponi® in Participants With Active Psoriatic Arthritis
• A Pilot Study of Technetium [99Tc] Methylene Diphosphonate in the Treatment of Psoriatic Arthritis
• Long Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic Arthritis
• An Efficacy Study of Secukinumab In Enthesitis of Psoriatic Arthritis Patients
• To Evaluate the Efficacy and Safety of SHR0302 Tablet in Subjects of Active Psoriatic Arthritis
• Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent
• A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease
• A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease-modifying Anti-rheumatic Drugs
• A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor
• EBIO - Enthesitis Biopsy Study
• A Study of Guselkumab in Participants With Active Psoriatic Arthritis
• Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
• Arthroscopic Synovectomy of the Wrist in Inflammatory Arthritis
• Study of Efficacy and Safety of Secukinumab in Chinese Subjects With Active PsA Compared to Placebo.
• A Study to Test Different Doses of BI 730357 and Find Out Whether They Reduce Symptoms in People With Active Psoriatic Arthritis
• Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
• A Study of Ixekizumab (LY2439821) in Children With Juvenile Idiopathic Arthritis Categories of Enthesitis-related Arthritis (Including Juvenile Onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis
• Danish Population-based Assessment of Psoriasis and Psoriatic Arthritis (DANPAPP)
• SystemIc iNflammation and Microvascular diSease PreventIon in psoRiatic diseasE
• Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)
• Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)
• Impact of Cannabis on Pain and Inflammation Among Patients With Rheumatoid or Psoriatic Arthritis
• Study to Demonstrate the Efficacy, Safety and Tolerability of Intravenous Secukinumab up to 52 Weeks in Subjects With Active Psoriatic Arthritis
• A Phase 4 Clinical Study of Brodalumab
• PsA T2T Statin Trial on Carotid and Coronary Atherosclerosis
• A Study in Pregnant Women With Chronic Inflammatory Diseases Treated With Cimzia (Certolizumab Pegol)
• Comparative Study to Evaluate the Pharmacokinetics of BAT2506 vs Simponi® in Healthy Subjects
• Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Have an Inadequate Response or Are Intolerant to Biologic DMARD Therapy
• Study to Evaluate the Efficacy and Safety of Filgotinib in Participants With Active Psoriatic Arthritis Who Are Naive to Biologic DMARD Therapy
• Low Dose Naltrexone for Chronic Pain in Osteoarthritis and Inflammatory Arthritis
• A Study to Evaluate the Safe and Effective Use of the Prefilled Safety Syringe or the Auto-injector for the Subcutaneous Self-injection of Bimekizumab Solution by Subjects With Active Psoriatic Arthritis
• GOLimumab and Methotrexate Versus Methotrexate in Very Early PsA (GOLMEPsA)
• Abatacept Bone Effects in Psoriatic Arthritis With Bone Biomarker
• Validation of the PsASon ULtrasound Scores in Patients With Psoriatic Arthritis Undergoing TReatment With Apremilast
• Tofacitinib for Reduction of Spinal Inflammation in Patients With Psoriatic ArthritiS PresenTing With Axial InvOlvement
• Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS
• A Study to Assess the Long-term Safety, Tolerability, and Efficacy of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
• A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic Arthritis
• Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, or Non-radiographic Axial Spondyloarthritis
• A Study to Evaluate the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
• A Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic Arthritis
• Efficacy and Safety of BMS-986165 Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA)
• Psoriatic Oligoarthritis Intervention With Symptomatic thErapy
• A Study of Guselkumab in Participants With Active Psoriatic Arthritis and an Inadequate Response to Anti-Tumor Necrosis Factor Alpha (Anti-TNF Alpha) Therapy
• A Study to Evaluate the Impact of Apremilast (CC-10004) on MRI Outcomes in Subjects With Psoriatic Arthritis
• An Extension Study of Subcutaneous Secukinumab in Patients With Juvenile Psoriatic Arthritis (JPsA) and Enthesitis Related Arthritis (ERA)
• Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.
• Severe Psoriatic Arthritis - Early intervEntion to Control Disease: the SPEED Trial
• Safety and Efficacy of Tofacitinib vs Methotrexate in the Treatment of Psoriatic Arthritis
• A Study of Golimumab in the Treatment of Indian Participants With Active Spondyloarthropathy of Ankylosing Spondylitis or Psoriatic Arthritis
• CBD Treatment in Hand Osteoarthritis and Psoriatic Arthritis.
• Impact of Nurse-led Programme With Carotid Ultrasound on Addressing Cardiovascular Risk in Patients With Arthritis
• PsA Secukinumab XCT Structural Progression Study
• Clinical Study of Efficacy and Safety of BCD-085 (Monoclonal Anti-IL-17 Antibody) in Psoriatic Arthritis
• Long-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.
• Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic Arthritis
• Clinical Impact of Acthar in the Psoriatic Arthritis Patient (CLIPS)
• A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
• A Study to Investigate BMS-986165 and Methotrexate in Healthy Male Patients
• A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Placebo and an Active Comparator in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
• Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately t
• A Study to Evaluate the Long-Term Safety and Efficacy of Bimekizumab in Subjects With Psoriatic Arthritis
• An Open-label, Long-term Extension Study With Filgotinib in Active Psoriatic Arthritis.
• The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients
• A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation
• Assessment of the Clinical and Ultrasound Response to Apremilast by Clinical Evaluation and by a Joint-periarticular-nail Ultrasound Index in Patients With Active Psoriatic Arthritis
• A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis Including Those Previously Treated With Biologic Anti -Tumor Necrosis Factor (TNF) Alpha Agent(s)
• A Study Evaluating the Efficacy and Safety of Guselkumab Administered Subcutaneously in Participants With Active Psoriatic Arthritis
• A Study of Ixekizumab (LY2439821) Versus Adalimumab in Participants With Psoriatic Arthritis
• Impact of Concomitant MTX on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active PsA
• A Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug
• A Study Comparing Upadacitinib (ABT-494) to Placebo in Participants With Active Psoriatic Arthritis Who Have a History of Inadequate Response to at Least One Biologic Disease Modifying Anti-Rheumatic Drug
• A Study to Assess Efficacy and Safety of Filgotinib in Active Psoriatic Arthritis
• Efficacy and Safety of Fecal Microbiota Transplantation in Peripheral Psoriatic Arthritis
• Secukinumab Safety and Efficacy in Juvenile Psoriatic Arthritis (JPsA) and Enthesitis-related Arthritis (ERA)
• Low Dose Naltrexone for Chronic Pain From Arthritis
• Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis
• Efficacy and Safety Study of SUNPG1623
• A Study to Evaluate the Dose Response Based on the Efficacy, Safety and Tolerability of Bimekizumab in Subjects With Active Psoriatic Arthritis Which is a Type of Inflammatory Arthritis
• Incidence of Hospitalizations for Serious Infections in Patients Receiving Biologic Anti-Inflammatories for Rheumatologic, Psoriatic, and Gastrointestinal Conditions: A Descriptive Analysis
• C.O.R.P.U.S.: Observational Cohort of Adult and Child Inflammatory Arthritis in France
• Effect of Secukinumab in the Treatment of Psoriatic Arthritis
• A Study of Subjects With Psoriatic Arthritis to Investigate the Effectiveness of Adalimumab Introduction Compared With Methotrexate Dose Escalation (CONTROL)
• Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to Placebo
• Apremilast Pregnancy Exposure Registry
• This Study Tests the Effect of Risankizumab on the Metabolism in the Liver of Five Additional Drugs to Study Possible Drug Interactions in Patients With Psoriasis With or Without Psoriatic Arthritis
• Study of Efficacy and Safety of Secukinumab in Psoriatic Arthritis and Axial Spondyloarthritis Patients With Active Enthesitis Including One Achilles Tendon Site
• Study of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton Involvement
• BI 655066/ABBV-066/Risankizumab Compared to Placebo in Patients With Active Psoriatic Arthritis
• A Study to Evaluate the Safety, Mode of Action and Clinical Efficacy of GSK3050002 in Subjects With Psoriatic Arthritis
• Study of Power Doppler Ultrasound (PDUS) to Measure Response of Secukinumab Treatment in Patients With Active Psoriatic Arthritis (PsA)
• A Study on Assessment of STELARA and Tumor Necrosis Factor Alpha Inhibitor Therapies in Participants With Psoriatic Arthritis
• Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Rheumatoid Diseases Who Are Naïve To Biologics Or Switched From Remicade
• A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
• Treatment With Apremilast in Patients With Psoriatic Arthritis
• Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
• Safety and Effectiveness of Live Zoster Vaccine in Anti-Tumor Necrosis Factor (TNF) Users (VERVE Trial)
• A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.
• Psoriasis-Arthritis & Bone Program
• Proof-of-concept Study of Forward Pharma (FP)187 in Patients With Mild/Moderate Psoriatic Arthritis
• Psoriatic Arthritis Treated With Liraglutide Therapy: a QUality of Life and Efficacy Study
• A Phase 2, Multicenter Open-Label Extension (OLE) Study With ABT-122 in Active Psoriatic Arthritis Subjects Who Have Completed a Preceding Study M14-197
• Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis
• A Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic Arthritis
• Efficacy and Safety Study of Guselkumab in the Treatment of Participants With Active Psoriatic Arthritis (PsA)
• Metformin in Psoriatic Arthritis
• A Study of Golimumab in Participants With Active Psoriatic Arthritis
• Does Etanercept Influence Tweak Modulation of Inflammation During Inflammatory Rheumatisms (Psoriatic Arthritis and Rheumatoid Arthritis)?
• The NOR-SWITCH Study
• Multiple Dose Study of UCB4940 in Subjects With Psoriatic Arthritis
• Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
• Efficacy of Golimumab in Combination With Methotrexate (MTX) Versus MTX Monotherapy, in Improving Dactylitis, in MTX naïve Psoriatic Arthritis Patients
• A Phase 3 Clinical Study of KHK 4827
• Study of Efficacy, Safety and Effect on Radiographic Progression of Brodalumab in Subjects With Psoriatic Arthritis
• Study of Efficacy and Safety of Brodalumab in Subjects With Psoriatic Arthritis
• Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis
• Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis
• Protocol for H.P. Acthar Gel in Moderately to Severely Active Psoriatic Arthritis
• Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
• Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept
• Extension Study up to 3 Years for Secukinumab in Psoriatic Arthritis
• Tofacitinib In Psoriatic Arthritis Subjects With Inadequate Response to TNF Inhibitors
• Efficacy And Safety Of Tofacitinib In Psoriatic Arthritis: Comparator Study
• Initial Treatment With Golimumab in Early PsA
• Efficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic Arthritis
• Efficacy at 24 Weeks With Long Term Safety, Tolerability and Efficacy up to 5 Years of Secukinumab in Patients of Active Psoriatic Arthritis
• A Study of Ixekizumab in Participants With Active Psoriatic Arthritis
• Study of Anti-Viral Prophylaxis for HBsAg(+) or HBcAb(+)/HBsAb(-) Patients Starting Anti-TNFα
• A Study to Assess the Safety and Effectiveness of Golimumab in Filipino Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
• Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
• A Clinical Study of Increased Dose of TA-650 in Patients With Psoriasis
• A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis
• AMG 827 in Subjects With Psoriatic Arthritis
• HUmira in Psoriatic Arthritis
• Extension Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis
• Efficacy at 24 Weeks and Long Term Safety, Tolerability and Efficacy up to 2 Years of Secukinumab (AIN457) in Patients With Active Psoriatic Arthritis (PsA)
• A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)
• Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)
• PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
• PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
• A Study of RO5310074 in Patients With Psoriatic Arthritis
• Role of Oral and Intestinal Microbiota in Rheumatoid Arthritis (RA)
• Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
• National Psoriasis Foundation - Dendritic Cell-Specific Transmembrane Protein (DC-Stamp) Biomarker Study
• TIght COntrol of Psoriatic Arthritis
• Golimumab Safety and Surveillance Program Using the Ingenix NHI Database
• A Study of the Safety and Efficacy of Ustekinumab in Patients With Psoriatic Arthritis With and Without Prior Exposure to Anti-TNF Agents
• T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade
• A Study of the Safety and Effectiveness of Ustekinumab in Patients With Psoriatic Arthritis
• A 24 Week Open Label Study of the Utility of Adalimumab in Active Axial Forms of Psoriatic Arthritis
• To Demonstrate the Relative Bioavailability, Parallel Study Of Leflunomide 20 mg Tablets Under Fasting Conditions
• Single Dose PG102 in Patients With Active Psoriatic Arthritis
• An Observational Study of Infliximab Injection in Ankylosing Spondylitis, Rheumatoid Arthritis, Psoriatic Arthritis and Psoriasis Participants
• Study Evaluating the Safety of Enbrel (Etanercept)
• A Placebo-controlled Study With an Extension Examining the Safety and Efficacy of Alefacept in Psoriatic Arthritis
• Study of the Safety and Efficacy of the Human Anti-TNF Monoclonal Antibody Adalimumab in Subjects With Moderately to Severely Active Psoriatic Arthritis
• Study of the Safety and Efficacy of Adalimumab in Subjects With Moderate to Severely Active Psoriatic Arthritis Subjects With Inadequate Response to Disease Modifying Anti-Rheumatic Drug Therapy
• Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis
• Rituxan With or Without Methotrexate in Psoriatic Arthritis
• Psoriasis Longitudinal Assessment and Registry (PSOLAR)
• Centocor Microarray Study of Patients
• Phase II Study of Apremilast (CC-10004) in Adults With in Psoriatic Arthritis
• Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis
• A Canadian Open-Label Study to Evaluate the Safety and Effectiveness of Adalimumab When Added to Inadequate Therapy for the Treatment of Psoriatic Arthritis (PsA) (ACCLAIM)
• Remicade Study in Psoriatic Arthritis Patients Of Methotrexate-Naïve Disease (RESPOND) (Study P04422)
• Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis
• Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists
• Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists
• An Effectiveness and Safety Study of CNTO 1275 in Patients With Active Psoriatic Arthritis
• Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis
• PsA Treatment With hOKT3γ1 (Ala-Ala)
• Safety and Efficacy Study of Adalimumab in Patients With Active Psoriatic Arthritis (PsA)
• Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain
• Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis
• TNFalfa Blocking Treatment of Spondylarthropathies
• REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®)
• Enbrel® in Psoriatic Arthritis
• Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis
• Safety, Efficacy and Pharmacokinetics of an Antibody for Psoriatic Arthritis
• A Study of the Safety and Effectiveness of Infliximab for the Treatment of Psoriatic Arthritis
• A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis